Skip to main content

UNITED CAPITAL FINANCIAL ADVISORS, LLC

Position in IDXX — Idexx Laboratories Inc /De

CIK 1463217 IRVING, TX

Position in IDXX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,004,261
+$203,339 QoQ
Shares Held
3,567
+34.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in IDXX Over Time

Shares Held

Position Value (USD)

Derivatives in IDXX

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
0
PutValue
$1,860,004
PutShares
3,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $56,202,433 across 15 Diagnostics & Research names. IDXX ranks #4 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 IDXX
Idexx Laboratories Inc /De
This page
3,567 $2,004,261

All Filings in IDXX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,004,261 3,567
2025-12-31 $1,800,922 2,662
2025-09-30 $1,619,586 2,535
2025-06-30 $1,091,451 2,035
2025-03-31 $938,588 2,235
2024-12-31 $1,011,274 2,446
2024-09-30 $1,224,653 2,424
2024-06-30 $1,180,485 2,423
2024-03-31 $1,341,186 2,484
2023-12-31 $1,449,790 2,612
2023-06-30 $239,061 476
2022-12-31 $3,038,078 7,447
2022-09-30 $2,460,767 7,553
2022-06-30 $2,666,249 7,602
2022-03-31 $4,095,838 7,487
2022-03-31 $1,860,004 3,400
2021-12-31 $4,960,837 7,534
2021-09-30 $4,829,675 7,766
2021-06-30 $4,953,246 7,843
2021-03-31 $3,829,829 7,827
2020-12-31 $4,097,434 8,197
2020-09-30 $3,426,346 8,716
2020-06-30 $25,092 76
2020-06-30 $3,591,480 10,878
2020-03-31 $5,179,091 21,380